All stocks / PURE
PURE BIOSCIENCE, INC. PURE
PURE Bioscience (PURE): shares outstanding up 25% in a year and the latest annual figures in plain language. Each fact links to its SEC filing.
Market listing
- Full name
- PURE BIOSCIENCE
- Market tier
- OTCQB
- Trading status
- Active
- Last trade
- 09:30:01
- Website
- www.purebio.com/
News headlines
The financial report, and what it means
Annual figures to 2026-07-31- Revenue
- $2,318,000
- Net loss
- ($2,483,000)
It spends more than it earns
Under strainCustomers paid it $2.3 million in the year. It lost $2.5 million. For every $1 that came in, about $2.07 went out.
- Cash and cash equivalents
- $569,000
- Net cash used in operating activities
- ($1,738,000)
The cash could run out soon
Under strainIt had $569,000 in the bank and used about $144,833 a month. At that pace the money lasts about 4 months unless it borrows or sells more shares.
- Total assets
- $1,193,000
- Total liabilities
- $7,592,000
It owes more than it owns
Under strainEverything the company owns adds up to $1.2 million. Its debts and unpaid bills add up to $7.6 million. That is about $6.36 owed for every $1 owned.
What this adds up to
3 of 3 checks show strain. It spends more than it earns. The cash could run out soon. It owes more than it owns. These are facts from the company's own reports, not a recommendation.
Signals
Shares outstanding rose from 111,886,473 (2025-10-29) to 140,201,055 (2026-10-29), up 25%.
Rule: Shares outstanding up 20% or more in 12 months. Source record
Estimated float about 140,201,055 shares as of 2026-10-29: 140,201,055 outstanding minus 0 held by 0 reporting insider(s).
Rule: Estimated: shares outstanding minus the latest holdings insiders reported on Forms 3/4/5. Holders of 5% or more (13D/13G) are not yet subtracted. Source record
Shares outstanding
Source: SEC filingsPrice chart
Chart by TradingView. We do not store or publish prices. Live quote on OTC Markets
Recent filings
Common questions about PURE
Does PURE file reports with the SEC?
Yes. PURE Bioscience files with the SEC under company number 0001006028. The most recent filing we hold is a 8-K dated 2026-10-29.
Source recordHow many PURE shares are outstanding?
140,201,055 shares as of 2026-10-29, as reported to the SEC. That is up 25% from 111,886,473 on 2025-10-29.
Source recordHas PURE filed reports late?
We found no late-filing notices (NT 10-K or NT 10-Q) in its last 12 months of SEC filings.
Who runs PURE Bioscience?
Officers named in its insider filings: Jeffrey Scott Kitchell (President, Corporate Secretary).
Source recordIs PURE Bioscience making money?
Customers paid it $2.3 million in the year. It lost $2.5 million. For every $1 that came in, about $2.07 went out. (Annual figures to 2026-07-31. Facts from the company's own report, not a recommendation.)
Source record